Shaun Furlong

Chief Financial Officer

Professional Overview
Shaun Furlong is an accomplished financial executive with extensive experience in the healthcare and financial services industries. As the Chief Financial Officer of Allergy Therapeutics, he leverages his deep expertise in financial reporting, strategic planning, and operational optimization to drive the company's financial success and support its growth initiatives.

Experience Summary

Current Role
As the Chief Financial Officer of Allergy Therapeutics, Shaun is responsible for leading the company's financial strategy, overseeing financial reporting and analysis, managing risk, and ensuring the efficient allocation of resources. He collaborates closely with the executive team to align financial objectives with the company's overall business strategy, and his strategic decision-making has been instrumental in positioning Allergy Therapeutics for continued growth and profitability.

Career Progression
Shaun's career journey has been marked by progressive leadership roles within prominent organizations. Prior to his current position, he served as the Group Financial Controller at Allergy Therapeutics, where he played a pivotal role in enhancing the company's financial processes and reporting capabilities. Earlier in his career, Shaun held various financial management positions at American Express Services Europe Ltd, Legal & General, Hastings Direct, Ricardo, Volution Group plc, Technetix Group Ltd, Doosan Power Systems, and The Body Shop, gaining valuable experience across the financial services, manufacturing, and retail sectors.

Academic Background
Shaun holds a PhD in Polymer Chemistry and a BSc in Chemistry, both from the University of Sussex. His advanced academic credentials and deep understanding of scientific principles have contributed to his ability to navigate complex financial and operational challenges in the healthcare industry.

Areas of Expertise

• Financial planning and analysis

• Strategic financial management

• Accounting and reporting standards

• Risk management and compliance

• Mergers, acquisitions, and integration

• Financial transformation and optimization

• Cross-functional collaboration and leadership

Professional Impact
Throughout his career, Shaun has demonstrated a track record of driving measurable improvements in financial performance, operational efficiency, and organizational agility. His expertise in financial reporting and strategic decision-making has enabled the companies he has worked for to enhance their competitive positioning, optimize resource allocation, and achieve their growth objectives.

Conclusion
Shaun Furlong's diverse industry experience, strong technical competencies, and proven leadership skills make him a valuable asset to Allergy Therapeutics. As the Chief Financial Officer, he is poised to continue contributing to the company's financial success and positioning it for long-term, sustainable growth in the dynamic healthcare industry.